Companion Diagnostics Market Research Reports & Industry Analysis
The companion diagnostics market is one of the fastest growing segments of the IVD and clinical lab services markets. In the United States, over half of all FDA approvals for companion diagnostics have occurred since 2010. The closely associated pharmacodiagnostics IVD market is expected to grow annually by over 20%. The wild success of reference laboratories in the companion diagnostics market even prompted the unprecedented expansion of FDA oversight over laboratory developed tests (LDTs).
Companion diagnostics are increasingly integral to the approval of some new pharmaceuticals, illustrating which individuals are most likely to benefit from the drug. With the approval of CDx-assisted therapies, new high-growth markets are opened for lab tests and IVD products.
Companion diagnostics (CDx) include in vivo or medical imaging procedures and in vitro diagnostic (IVD) lab tests used to determine the efficacy of a particular therapy, most commonly pharmaceutical. Genome research in recent decades has illuminated and detailed the role genetics play in drug metabolism and disease etiology. Drugs can now be paired with IVD and medical imaging tests for prescription decisions and therapeutic monitoring. In vitro companion diagnostics are largely molecular assays, though additional formats include immunohistochemistry (IHC) and immunoassays, and are offered as test kits, analyte specific reagents, and laboratory developed tests (LDTs) or a lab testing service.
The majority of companion diagnostics are pharmacodiagnostic lab tests used to assess an individual’s response to drug therapy. Pharmacodiagnostics represents a major front in a healthcare system-wide push towards personalized medicine. Pharmacodiagnostic tests can be used to determine patient response to clopidogrel anticoagulant drugs, appropriate drug dosage, and the prescription of oncology drugs based on genetic markers.
Stay abreast of fast-paced and promising companion diagnostics markets with MarketResearch.com’s collection of market research studies. We offer a wide selection of studies treating companion diagnostic regulation, regional and disease-specific market development, product and test pipelines, and companion diagnostic product market tracking.
Companion Diagnostics Industry Research & Market Reports
-
Companion Diagnostic Market, by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, and Others), by Technology (Real Time-Polymerase Chain Reaction (PCR), Gene Sequencing, Fluorescence in situ Hybridization, and Others),
... America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Companion diagnostic is a diagnostic tool used by healthcare professionals to determine whether a particular ... Read More
-
The 2023-2028 World Outlook for Oncology Companion Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Companion Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Companion Animal Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Companion Diagnostics Assay Kits and Reagents
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2023-2028 World Outlook for Tissue Diagnostic Devices
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Global Companion Diagnostics Market 2022-2028
... product. The majority of companion diagnostics are for oncology treatment. The global companion diagnostics market is anticipated to reach valuation of ~USD 9,659 million by 2028, representing a CAGR of 13.2% from 2022 to 2028 ... Read More
-
IVD Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology & Cytology, Microbiology, and Others), Services (Clinical Research, Biostatistics & Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography
... Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography The global IVD contract research organization market is expected to grow from US$ 4,738.79 million in 2021 to ... Read More
-
Companion Diagnostics - Thematic Research
... of personalized, stratified, and precision medicine, and they herald a new era of treatment in which a patient’s treatment will become increasingly individualized. CDx are developed in parallel to the drug using the drug-diagnostic co-development ... Read More
-
Companion Diagnostics Market (Indication: Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... on the global companion diagnostics market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. ... Read More
-
2022 Global: Companion Diagnostics - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026
... global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6% during the forecast period. Market growth is driven by factors such ... Read More
-
The World Market for Veterinary Diagnostics, 5th Edition
... animal diagnostics. The report provides analysis of major veterinary disease markets as well as overall market performance and development. Data points provided include: Total Global Animal Diagnostic Testing Market, 2021-2026 (in millions $ at manufacturer ... Read More
-
Multiplex Assay Market by Type (Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assay, and Other Multiplex Assays), Product (Reagents & Consumables, Instruments & Accessories, and Software & Services), Application (Clinical Diagnostics, Research & Development, and Companion Diagnostics), and End User (Hospitals, Clinical Laboratories, Research Institutes, And Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020–2030
... Companion Diagnostics), and End User (Hospitals, Clinical Laboratories, Research Institutes, And Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020–2030 The global multiplex assay market was valued at $1,940.49 million in 2020, and ... Read More
-
North America Companion Diagnostics Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... Certain factors that are driving the market growth include increasing demand and awareness for personalized medicine and targeted therapy, increasing cases of adverse drug reactions, and technological demands. The United States takes an exceptional approach ... Read More
-
India In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... USD 1990.99 million in 2026, registering a CAGR of nearly 7.10% during the forecast period. In the context of COVID-19, government organizations in various countries, research institutes, and many global and domestic companies are focusing ... Read More
-
Europe Companion Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... and diagnostic technologies. In addition, rising cases of adverse drug reactions related to drugs drive the need for companion diagnostics. The European market is driven by factors, such as improved efficacy/safety profiles of drugs, accelerated ... Read More
-
2022 Global Forecast for Companion Diagnostics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Companion Diagnostics Market: Current Analysis and Forecast (2021-2027)
... companion to a therapeutic drug to determine its applicability to a specific person. Moreover, the demand for companion diagnostic tests is on the rise for the early detection and screening of various cancers such as ... Read More
-
Multiplex Assay Market by Type (Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assay, and Other Multiplex Assays), Product (Reagents & Consumables, Instruments & Accessories, and Software & Services), Application (Clinical Diagnostics, Research & Development, and Companion Diagnostics), and End User (Hospitals, Clinical Laboratories, Research Institutes, And Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020–2030
... Companion Diagnostics), and End User (Hospitals, Clinical Laboratories, Research Institutes, And Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020–2030 Market Overview Fatpos Global has released a report titled Multiplex Assay Market - ... Read More
-
The World Market for Cancer Diagnostics, 2021
... cancer recurrence. The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity ... Read More
-
The World Market for Molecular Diagnostics Tests, 10th Edition
... indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various ... Read More
-
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities
... in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that ... Read More
-
Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2025- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
... industry and its impact on the health system. This report tackles the growing market interest in pharmacogenomics, targeted therapeutics, companion diagnostics and the associated market environment. In 2019, 11 personalized therapeutics gained approval from the ... Read More
-
Kalorama 2017 IVD Market Research Bundle (The Worldwide Market for In Vitro Diagnostic Tests, NGS, Companion, US IVD)
... reports, covering a range of IVD topics. The World Market for In Vitro Diagnostics, 10 th Edition. Published August 2016 United States In Vitro Diagnostics Markets Published July 2016 Companion Diagnostic Testing Markets Published April ... Read More
Research Assistance
